Skip to search formSkip to main contentSkip to account menu

WAY 133537

Known as: WAY-133537 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

CyclobutanesNitriles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Effect of the potassium channel opener WAY‐133537 on the overactive bladder of spinalized rats
To test the efficacy of WAY‐133537 for the treatment of overactive bladder (OAB) in a chronic paraplegic rat model. 
2004
2004
(−)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a Novel ATP-Sensitive Potassium Channel Opener: Hemodynamic Comparison to ZD-6169, WAY…
The therapeutic utility of KATP channel opening agents (KCOs) in the treatment of overactive bladder may be limited by… 
2002
2002
(−)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary…
ATP-sensitive potassium (KATP) channel openers (KCOs) have been shown to inhibit spontaneous myogenic contractile activity of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)